Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? (Q37355913)

19 August 2017

1 reference

title

Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? (English)

1 reference

19 August 2017

0 references

0 references

1 reference

1 reference

1 reference

Eline Verhoye

1

1 reference

19 August 2017

Michel R Langlois

series ordinal

2

1 reference

19 August 2017

Asklepios Investigators

series ordinal

3

1 reference

19 August 2017

language of work or name

1 reference

1 January 2009

1 reference

Clinical Chemistry and Laboratory Medicine

19 August 2017

1 reference

19 August 2017

47

1 reference

19 August 2017

2

1 reference

19 August 2017

128-137

1 reference

Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles

19 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Low density lipoprotein oxidation and its pathobiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Structural modifications of HDL and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Antioxidant defenses and lipid peroxidation in human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Rationale, design, methods and baseline characteristics of the Asklepios Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Association between serum ferritin and circulating oxidized low-density lipoprotein levels in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.037

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.037

1 reference

19 August 2017

1 reference